The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

American Cancer Society Got It Wrong: They Need to Apologize Study Confirms Prostate Cancer Test Sav

bdhilton
bdhilton CSN Member Posts: 872 Member
edited March 2014 in Prostate Cancer #1
The following is a statement released this summer by Project Zero, the Project to End Prostate Cancer. With a new study showing the PSA test reduces the prostate cancer death rate by 44 percent, ZERO – The Project to End Prostate Cancer – demands...

/quest/Fall2010/article3.html

Comments

  • bdhilton
    bdhilton CSN Member Posts: 872 Member
    Here is the correct url
    http://www.drcatalona.com/quest/Fall2010/article3.html

    “With 2010 statistics predicting a 17 percent jump in prostate cancer deaths – the largest in more than a decade – the ACS should be encouraging men to take control of their lives and get tested,” Lockwood said. “Instead, ACS is more concerned about sexual side effects rather than saving men’s lives - though it quickly changed its tune when it said the same thing last year about women getting a mammogram.”

    “Like the mammogram, we acknowledge the PSA test is not perfect - it cannot distinguish slow-growing tumors from rapidly growing ones - but until new methods for testing are developed, it’s still the best tool available for early detection and prompt treatment of prostate cancer,” Lockwood said.